Vice President, Drug Safety and Pharmacovigilance
City Therapeutics
Cambridge, MA · $385k–$405k a year · Posted November 3, 2026
Just laid off? Start here: a plan for the first weeks
Want recruiters in Clinical to be able to find you?
Roles at this level, like this one at City Therapeutics, are often filled through recruiters.
See every open role at City Therapeutics
More in Massachusetts job market · Pharmaceuticals & Biotech · Clinical jobs
Similar jobs
- Vice President, Pharmaceutical Development · Kymera Therapeutics · Watertown, MA
- Vice President, Pharmaceutical & Process Development · Stoke Therapeutics · Bedford, MA
- Vice President, Clinical Development - Ophthalmology · Stoke Therapeutics · Bedford, MA
- 21GRAMS- VP, Medical Strategy Director · Real Chemistry · Boston, MA
- Vice President, Franchise Clinical Lead, Oncology · Takeda Development Center Americas · Cambridge, MA
- Head of Gastrointestinal & Inflammation, Global Medical Safety (Vice President) · Takeda Development Center Americas · Boston, MA
Where Cambridge, MA ranks
Where Cambridge, MA placed in our monthly rankings, month by month. Each month stays online at its own address.
November 2026
- #1Best cities for healthcare pay after cost of living$180k · of 24
- #1Best cities for director and executive jobs53% · of 100
- #1Best cities for director and executive jobs in the Northeast53% · of 70
- #1Best cities for director and executive jobs in New England53% · of 28
- #2Best cities for life sciences and biotech jobs579 openings · of 41
- #2Cities with the most jobs that do not need a four-year degree in New England59 jobs · of 14
Rankings about clinical jobs
- Best cities for clinical jobs #1 New York (202 openings)
- Employers with the most clinical jobs #1 Veterans Health Administration (215 roles)
About the job
... Vice President, Drug Safety and Pharmacovigilance Cambridge, MA Vice President, Drug Safety and Pharmacovigilance City Therapeutics is engineering the future of RNAi-based medicine. Founded by pioneers in RNA interference, we combine next-generation trigger molecule...